Diagnostic LabsTest Menu
Popular Tests
2722
HLA Loss of Heterozygosity Evaluation
This test is intended for patients with confirmed disease relapse post-hematopoietic cell transplant to evaluate the presence or absence of genomic loss of heterozygosity in the HLA region in malignant cell populations. USA test status: This is a laboratory developed test (LDT).
5603
Neonatal Alloimmune Thrombocytopenia (NAIT)-Initial Testing Maternal with Paternal
This order set includes: Platelet Antigen Genotyping on parents, Platelet Antibody Identification Panel on mother and maternal serum crossmatched with paternal platelets. To complete the workup, concurrently order NAIT-Initial Paternal (test code 5703) USA test status: This is a laboratory developed test (LDT).
3111
DAT Negative Hemolytic Anemia Evaluation
Includes: ABO/Rh, Direct Antiglobulin Tests (including IgA detection), Elution (routine and enhanced), and antibody detection tests (routine and enhanced). Additional tests as necessary based upon results determined by Immunohematology Reference Lab. USA test status: This is a laboratory developed test (LDT).
5544
Platelet Autoantibodies
This assay detects direct and indirect glycoprotein-specific antibodies in eluates prepared from washed patient platelets. USA test status: This is a laboratory developed test (LDT).
9000
Drug-Dependent Platelet Antibody
This assay employs flow cytometric detection of drug-dependent platelet antibodies for several drugs. USA test status: This is a laboratory developed test (LDT).
4895
Hereditary Hemorrhagic Telangiectasia Panel
This panel is designed for the detection of germline variants in 6 genes known to cause hereditary hemorrhagic telangiectasia: Next Generation Sequencing (NGS) only; NGS with reflex to Array Comparative Genomic Hybridization (aCGH); NGS with concurrent aCGH (both testing methodologies performed simultaneously); aCGH only. USA test status: This is a laboratory developed test (LDT).